There are now several experimental treatments vying to be tested, but each must be greenlit by national regulatory authorities whenever and wherever an outbreak occurs. There remain deeply divergent positions among scientists about how to design outbreak trials, specifically whether studies that don’t compare treatments to placebos can generate useful data
Quick Read
China is making a bid to use its Ebola vaccine in the Democratic Republic of the Congo. It’s a move that could further complicate efforts to test a crowded field of vaccines and therapies in the context of a waning outbreak
Quick Read
The infection, an emerging threat, has killed virtually all of its victims so far in India
Quick Read
New Ebola Tactics Raise Hope but May Sow ConfusionMay 25, 2018 |
Although there is optimism that the Ebola outbreak in central Africa can still be quickly contained, the fight is already becoming more complex, health experts said this week
Quick Read
Vaccines Alone Won’t Beat EbolaMay 24, 2018 |
A deep understanding of the Congo’s culture and time-honored public-health tactics are the keys to controlling the outbreak
Quick Read
A campaign to vaccinate people at risk of developing Ebola in the latest outbreak in the Democratic Republic of the Congo could begin by the end of this week, Tedros Adhanom Ghebreyesus, the director-general of the World Health Organization, said Sunday
Quick Read
Ethicists Call for More Scrutiny of ‘Human-Challenge’ TrialsApril 23, 2018 |
Members of a government ethics panel have renewed their criticisms of a controversial study in which volunteers are to be deliberately infected with the Zika virus
Quick Read
The World Health Organization (WHO) in Geneva, Switzerland, put the brakes on implementation of the world’s first dengue vaccine today when it recommended it only be used in people who have previously been infected with the disease—a move that will shrink the potential market for the vaccine’s producer, Sanofi Pasteur
Quick Read
